EVENT
[Open Seminar] Harvey Lodish, Ph.D.
June 19, 2024
Credits: WPI-Bio2Q
Credits: WPI-Bio2Q
Credits: WPI-Bio2Q
Keio University Human Biology-Microbiome-Quantum Research Center (WPI-Bio2Q) held an open seminar as follows:
| Date & Time | Wednesday, June 12, 2024, 16:00 -17:30 |
|---|---|
| Venue | (Hybrid) 1F Lounge, Center for Integrated Medical Research, Shinanomachi Campus, Keio University and on zoom |
| Title | New Technologies and Building Successful Biotechnology Companies to Treat Disease: A Personal History |
| Speaker | Harvey F. Lodish, Ph.D. Professor of Biology and Professor of Biological Engineering, Massachusetts Institute of Technology (USA) Lead author, “Molecular Cell Biology” Founder/scientific board member: Genzyme, Millennium Pharmaceuticals, Rubius Therapeutics, Tevard |
| Language | English |
Prof. Lodish highlighted the connection between academia and entrepreneurship in biotechnology, covering key aspects of starting a biotech company, intellectual property, and assembling a team with diverse expertise. The importance of scientists leveraging their expertise by consulting for or founding companies and the advantage of research institutes being located near biotech companies for collaboration was also discussed.
SHARE
More Bio2Q News
【11/13 Seminar】Bio2Q Open Seminar: Richard I. Morimoto, PhD
Keio University Human Biology-Microbiome-Quantum Research Center (WPI-Bio2Q) will hold a seminar as follows. This is an event for faculty, ...
【Publication】Identification and characterization of CXCL13 producers in bone tis...
Co-authored by researchers from Bio2Q and published in the journal International Immunology, this study clarifies how fasting alters the imm...
【Publication】Inhibition of Mincle signaling by chemically synthesized disacchari...
Co-authored by researchers at Bio2Q and published in Chemical Communications, this study discovered plant-derived compounds that suppress ex...
【Publication】Accurate, sensitive, and efficient chromatin accessibility quantifi...
Co-authored by researchers at Bio2Q and published in Nature Communications, this study developed a new analytical technology to accurately a...
【Publication】Mixed-class J-domain protein scaffolds promote expanded aggregate h...
Co-authored by researchers at Bio2Q and published in FEBS Letters, this study elucidates a new degradation mechanism by which human cells re...
